07:00 , May 1, 2014 |  BC Innovations  |  Distillery Therapeutics

Indication: Endocrine/metabolic disease

Indication Target/marker/pathway Summary Licensing status Publication and contact information Endocrine/metabolic disease Obesity Amylase a1A (AMY1A); AMY1B; AMY1C Genetic studies identified an association between copy number variants of the salivary amylase genes and obesity that could...